Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hack

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Geburtshilfe Und Frauenheilkunde|September 27, 2014
Percent Mammographic Density and Dense Area as Risk Factors for Breast CancerC Rauh, C C Hack, L Häberle, et al.
Breast Cancer Research : BCR|April 12, 2012
Characterizing mammographic images by using generic texture featuresLothar Häberle, Florian Wagner, Peter A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|July 31, 2018
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among PhysiciansPaul Gass, Michael Untch, Volkmar Müller, et al.
Breast Cancer Research and Treatment|May 5, 2018
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patientsMarius Wunderle, Paul Gass, Lothar Häberle, et al.
Breast Cancer Research and Treatment|March 13, 2013
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasisChristian R Loehberg, Katrin Almstedt, Sebastian M Jud, et al.
Archives of Gynecology and Obstetrics|June 10, 2017
Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO surveyEvelyn Klein, Matthias W Beckmann, Werner Bader, et al.
Archives of Gynecology and Obstetrics|March 24, 2017
Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study networkCarlo Fremd, Carolin C Hack, Andreas Schneeweiss, et al.
Frontiers in Immunology|December 27, 2016
Embracing Complexity beyond Systems Medicine: A New Approach to Chronic Immune DisordersAnje A Te Velde, Tjitske Bezema, Antoine H C van Kampen, et al.
Breast Care (Basel, Switzerland)|June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating LymphocytesFranziska Würfel, Ramona Erber, Hanna Huebner, et al.
Journal of the American College of Cardiology|July 21, 1998
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiogramsP A Grayburn, J L Weiss, T C Hack, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Geburtshilfe Und Frauenheilkunde|September 27, 2014
Percent Mammographic Density and Dense Area as Risk Factors for Breast CancerC Rauh, C C Hack, L Häberle, et al.
Breast Cancer Research : BCR|April 12, 2012
Characterizing mammographic images by using generic texture featuresLothar Häberle, Florian Wagner, Peter A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|July 31, 2018
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among PhysiciansPaul Gass, Michael Untch, Volkmar Müller, et al.
Breast Cancer Research and Treatment|May 5, 2018
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patientsMarius Wunderle, Paul Gass, Lothar Häberle, et al.
Breast Cancer Research and Treatment|March 13, 2013
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasisChristian R Loehberg, Katrin Almstedt, Sebastian M Jud, et al.
Archives of Gynecology and Obstetrics|June 10, 2017
Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO surveyEvelyn Klein, Matthias W Beckmann, Werner Bader, et al.
Archives of Gynecology and Obstetrics|March 24, 2017
Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study networkCarlo Fremd, Carolin C Hack, Andreas Schneeweiss, et al.
Frontiers in Immunology|December 27, 2016
Embracing Complexity beyond Systems Medicine: A New Approach to Chronic Immune DisordersAnje A Te Velde, Tjitske Bezema, Antoine H C van Kampen, et al.
Breast Care (Basel, Switzerland)|June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating LymphocytesFranziska Würfel, Ramona Erber, Hanna Huebner, et al.
Journal of the American College of Cardiology|July 21, 1998
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiogramsP A Grayburn, J L Weiss, T C Hack, et al.
Pageof 15